Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 6, 2005, Pages 1448-1452

  Rollison, Dana E ^a,b   Helzlsouer, Kathy J ^b   Halsey, Neal A ^b   Shah, Keerti V ^b   Viscidi, Raphael P ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; BK VIRUS; BLOOD BANK; BLOOD SAMPLING; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JC VIRUS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEROPREVALENCE; SIMIAN VIRUS 40; VIRUS INFECTION; VIRUS PARTICLE;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYMPHOMA, NON-HODGKIN; MALE; MARYLAND; MIDDLE AGED; ODDS RATIO; POLYOMAVIRUS INFECTIONS; RISK FACTORS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 20444406859     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0674     Document Type: Article

References (30)

1. American Cancer Society. Cancer facts and figures 2004. Atlanta (GA): American Cancer Society. Ref Type: Report; 2004.
2. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 2003;4:110-9.
3. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003;125:1723-32.
4. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003;22:5108-21.
5. Vilchez RA, Butel JS. SV40 in human brain cancers and non-Hodgkin's lymphoma. Oncogene 2003;22:5164-72.
6. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1-12.
7. Shah KV. Polyoma viruses (JC virus, BK virus, and simian virus 40) and human cancer. In: Goedert JJ editor. Infectious causes of cancer: targets for intervention. Totowa (NJ): Humana Press, Inc.; 2001. p. 461-74.
8. Diamandopoulos GT. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972;176:173-5.
9. Daibata M, Nemoto Y, Kamioka M, Imai S, Taguchi H. Simian virus 40 in Japanese patients with lymphoproliferative disorders. Br J Haematol 2003;121:190-1.
10. Martini F, Dolcetti R, Gloghini A, et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998;78:669-74.
11. Nakatsuka S, Liu A, Dong Z, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003;63:7606-8.
12. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359:851-2.
13. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-23.
14. Rizzo P, Carbone M, Fisher SG, et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999;116:470-3S.
15. Capello D, Rossi D, Gaudino G, Carbone A, Gaidano G. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003;361:88-9.
16. MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF. Association between simian virus 40 DNA and lymphoma in the United kingdom. J Natl Cancer Inst 2003;95:1001-3.
17. Yazdi AS, Puchta U, Flaig MJ, Sander CA. Lack of evidence for the presence of Simian virus 40 DNA in cutaneous lymphomas. J Invest Dermatol 2003;121:212-3.
18. Engels EA, Rodman LH, Frisch M, Goedert JJ, Biggar RJ. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int J Cancer 2003;106:283-7.
19. Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003;95:532-9.
20. Holly EA, Bracci PM. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003;158: 316-27.
21. Rollison DE, Page WF, Crawford H, et al. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine. Am J Epidemiol 2004;160:317-24.
22. de Sanjose S, Shah KV, Domingo-Domenech E, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003;104:522-4.
23. Engels EA, Viscidi RP, Galloway DA, et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 2004;96:1368-74.
24. Rothman N, Cantor KP, Blair A, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997;350:240-4.
25. Viscidi RP, Rollison DE, Viscidi E, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003;10:278-85.
26. Carter JJ, Madeleine MM, Wipf GC, et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003;95:1522-30.
27. Wei LJ, Lin Dy, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-78.
28. Shah KV, Galloway DA, Knowles WA, Viscidi RP. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev Med Virol 2004;14:231-9.
29. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1-12.
30. Butel JS, Jafar S, Wong C, et al. Evidence of SV40 infections in hospitalized children. Hum Pathol 1999;30:1496-502.